In the development cohort, the comparison of mean pre-treatment SII values in patients having CR (mean: 696,542) or PR (mean: 627,892) and in those having SD + PD (mean: 1,270,000) showed a trend for a significant difference.
← all excerpts
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier).
1
—
—